Efficacy and Safety of Intensity‐Modulated Radiotherapy Combined With Regorafenib With or Without Immune Checkpoint Inhibitors as Second‐Line Treatment for Advanced Hepatocellular Carcinoma: A Real‐World Cohort Study From a Single Center

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Intensity‐Modulated Radiotherapy Combined With Regorafenib With or Without Immune Checkpoint Inhibitors as Second‐Line Treatment for Advanced Hepatocellular Carcinoma: A Real‐World Cohort Study From a Single Center
Authors: Xin, Lingxia1 (AUTHOR), Li, Zhiyu2 (AUTHOR), Zhai, Yirui1 (AUTHOR), Wang, Liming2 (AUTHOR), Ye, Feng3 (AUTHOR), Sun, Yongkun4 (AUTHOR), Zhang, Wen4 (AUTHOR), de Castria, Tiago Biachi5,6 (AUTHOR), Satapathy, Sanjaya K.7 (AUTHOR), Shelat, Vishal G.8 (AUTHOR), Mok, Shaffer R. S.9 (AUTHOR), Wu, Jennifer10 (AUTHOR), Wang, Shulian1 (AUTHOR), Liu, Yueping1 (AUTHOR), Song, Yongwen1 (AUTHOR), Tang, Yuan1 (AUTHOR), Jing, Hao1 (AUTHOR), Fang, Hui1 (AUTHOR), Qi, Shunan1 (AUTHOR), Lu, Ningning1 (AUTHOR)
Source: Cancer Medicine. Apr2026, Vol. 15 Issue 4, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457634
DOI:10.1002/cam4.71745